EarningsQ4 2019 Earnings Report

Vir Biotechnology (VIR) Q4 2019 Earnings Report

4 Followers

MX:VIR Q4 2019 EPS Results

Actual EPS-$13.07

Consensus EPS―

Beat/Miss―

One Year Ago EPS-$4.44

Actual Revenue$18.05M

Expected Revenue―

Beat/Miss―

YoY Revenue Growth―

QuarterQ4 2019

Date03/26/2020

TimeAfter Close

Conference CallThursday, March 26, 2020

MX:VIR Upcoming Earnings

Vir Biotechnology's next earnings date is estimated for October 29, 2026, based on past reporting schedules.

No earnings call audio is available for this earnings event.

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Oct 29, 2026	2026 (Q3)	-13.61 / -	-21.545	―
Aug 05, 2026	2026 (Q2)	6.13 / 8.65	-14.731	158.75% (+23.39)
May 06, 2026	2026 (Q1)	-1.77 / -15.65	-16.204	3.41% (+0.55)
Feb 23, 2026	2025 (Q4)	-9.04 / -5.71	-13.995	59.21% (+8.29)
Nov 05, 2025	2025 (Q3)	-15.54 / -21.54	-28.726	25.00% (+7.18)
Aug 06, 2025	2025 (Q2)	-13.31 / -14.73	-18.782	21.57% (+4.05)
May 07, 2025	2025 (Q1)	-15.39 / -16.20	-8.839	-83.33% (-7.37)
Feb 26, 2025	2024 (Q4)	-16.06 / -13.99	-15.836	11.63% (+1.84)
Oct 31, 2024	2024 (Q3)	-19.37 / -28.73	-22.465	-27.87% (-6.26)
Aug 01, 2024	2024 (Q2)	-16.48 / -18.78	-26.701	29.66% (+7.92)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed